Univest Financial’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,329
Closed -$206K 278
2024
Q3
$206K Buy
+1,329
New +$198K 0.01% 271
2023
Q2
Sell
-1,677
Closed -$237K 119
2023
Q1
$237K Sell
1,677
-159
-9% -$22.7K 0.07% 89
2022
Q4
$287K Sell
1,836
-304
-14% -$43.7K 0.09% 85
2022
Q3
$263K Sell
2,140
-91
-4% -$12K 0.09% 86
2022
Q2
$297K Sell
2,231
-98
-4% -$13.4K 0.1% 82
2022
Q1
$319K Sell
2,329
-284
-11% -$39.6K 0.09% 86
2021
Q4
$452K Sell
2,613
-321
-11% -$48.8K 0.12% 69
2021
Q3
$426K Sell
2,934
-282
-9% -$41.3K 0.12% 69
2021
Q2
$424K Sell
3,216
-5
-0.2% -$655 0.12% 70
2021
Q1
$413K Buy
3,221
+115
+4% +$14.2K 0.12% 68
2020
Q4
$370K Sell
3,106
-367
-11% -$44.7K 0.11% 78
2020
Q3
$398K Buy
+3,473
New +$410K 0.13% 71

Other funds holding DGX

Univest Financial's DGX Position: Q4 2024 in Review

Univest Financial sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 1,329 shares — an estimated $206K sold.

Univest Financial first reported a position in DGX in Q3 2020 and held it in 12 quarters. The position peaked at $452K in Q4 2021. 897 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Univest Financial reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Univest Financial sold 1,329 Quest Diagnostics shares in Q4 2024, an estimated $206K.
  • Univest Financial first reported a position in Quest Diagnostics in Q3 2020 and held it in 12 quarters.
  • Univest Financial's Quest Diagnostics position peaked at $452K in Q4 2021.
  • 897 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Univest Financial's 13F filing for Q4 2024, filed 12 Feb 2025.